← Back to Search

Coenzyme Q10

coQ10B for In Vitro Fertilization

Phase 2
Waitlist Available
Research Sponsored by Trio Fertility
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
1. Women age \>37 and \<43 years undergoing their first in vitro fertilization (IVF) cycle
2. Day 3 follicle-stimulating hormone (FSH) \<12 IU/L with serum estradiol \<250 pmol/L and normal thyroid-stimulating hormone (TSH) and Prolactin
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

Summary

The objective of this study is to determine if ubiquinol will result in improved reproductive outcomes in older women at a reduced oral dose compared to current standard treatment with ubiquinone.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Fertilized oocyte percentage
Secondary study objectives
MII oocyte percentage
Protein structural change
Reproductive outcome
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: coQ10BExperimental Treatment1 Intervention
Eligible subjects will be receiving ubiquinol 100 mg prior to their IVF cycle.
Group II: coQ10 AExperimental Treatment1 Intervention
Eligible subjects will be receiving ubiquinone 200 mg prior to their in vitro fertilization (IVF) cycle.
Group III: ControlActive Control1 Intervention
Subjects are not receiving coQ10 supplementation.

Find a Location

Who is running the clinical trial?

Trio FertilityLead Sponsor
2 Previous Clinical Trials
130 Total Patients Enrolled
~60 spots leftby Sep 2026